Insights into the structure and activity of prototype foamy virus RNase H

Retrovirology

Volumn 9, Issue , 2012, Pages

  Leo, Berit ^a   Hartl, Maximilian J ^a   Schweimer, Kristian ^a   Mayr, Florian ^a   Wöhrl, Birgitta M ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Basic loop; C helix; NMR; PFV; Retroviral RNase H

Indexed keywords

MAGNESIUM ION; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; DIVALENT CATION; MAGNESIUM;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANISOTROPY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PURIFICATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; EXPRESSION VECTOR; GEL PERMEATION CHROMATOGRAPHY; HETERONUCLEAR SINGLE QUANTUM COHERENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STRUCTURE; SEQUENCE ALIGNMENT; SPUMA VIRUS; VIRUS TITRATION; CHEMISTRY; COENZYME; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; RNA STABILITY; SEQUENCE HOMOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN SPUMARETROVIRUS;

AMINO ACID SEQUENCE; CATIONS, DIVALENT; COENZYMES; HUMANS; KINETICS; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RIBONUCLEASE H; RNA STABILITY; SEQUENCE HOMOLOGY, AMINO ACID; SPUMAVIRUS;

EID: 84856803486     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-14     Document Type: Article

References (47)

1. Linial M. Foamy viruses. Fields Virology 2007, 2245-2262. Lippincott Williams & Wilkins, Philadelphia, Knipe DM, Howley PM.
2. Rethwilm A. Foamy viruses. Topley & Wilson's Microbiology and Microbial Infections - Virology 2005, 1304-1321. London:Hodder Arnold, ter Meulen V, Mahy BWJ.
3. Rethwilm A. Molecular biology of foamy viruses. Med Microbiol Immunol 2010, 199:197-207. 10.1007/s00430-010-0158-x, 20445989.
4. Hartl MJ, Mayr F, Rethwilm A, Wöhrl BM. Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology 2010, 7:5. 10.1186/1742-4690-7-5, 2835651, 20113504.
5. Hartl MJ, Bodem J, Jochheim F, Rethwilm A, Rösch P, Wöhrl BM. Regulation of foamy virus protease activity by viral RNA - a novel and unique mechanism among retroviruses. J Virol 2011, 85:4462-4469. 10.1128/JVI.02211-10, 3126251, 21325405.
6. Moelling K, Bolognesi DP, Bauer H, Büsen W, Plassmann HW, Hausen P. Association of retroviral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol 1971, 234:240-243.
7. Gilboa E, Mitra SW, Goff S, Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell 1979, 18:93-100. 10.1016/0092-8674(79)90357-X, 509527.
8. Repaske R, Hartley JW, Kavlick MF, O'Neill RR, Austin JB. Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase. J Virol 1989, 63:1460-1464. 247852, 2464706.
9. Tisdale M, Schulze T, Larder BA, Moelling K. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J Gen Virol 1991, 72:59-66. 10.1099/0022-1317-72-1-59, 1703563.
10. Schultz SJ, Champoux JJ. RNase H activity: Structure, specificity, and function in reverse transcription. Virus Res 2008, 134:86-103. 10.1016/j.virusres.2007.12.007, 2464458, 18261820.
11. Pullen KA, Rattray AJ, Champoux JJ. The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 1993, 268:6221-6227.
12. Huber HE, Richardson CC. Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase. J Biol Chem 1990, 265:10565-10573.
13. Luo GX, Sharmeen L, Taylor J. Specificities involved in the initiation of retroviral plus- strand DNA. J Virol 1990, 64:592-597. 249148, 1688626.
14. Wöhrl BM, Moelling K. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry (N Y) 1990, 29:10141-10147.
15. Furfine ES, Reardon JE. Human immunodeficiency virus reverse transcriptase ribonuclease H: Specificity of tRNAlys3-primer excision. Biochemistry (N Y) 1991, 30:7041-7046.
16. Pullen KA, Ishimoto LK, Champoux JJ. Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. J Virol 1992, 66:367-373. 238296, 1370087.
17. Smith JS, Roth MJ. Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus- strand primer, tRNA(lys3). J Biol Chem 1992, 267:15071-15079.
18. Evans DB, Brawn K, Deibel MR, Tarpley WG, Sharma SK. A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active. J Biol Chem 1991, 266:20583-20585.
19. Hostomsky Z, Hostomska Z, Hudson GO, Moomaw EW, Nodes BR. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 1991, 88:1148-1152. 10.1073/pnas.88.4.1148, 50974, 1705027.
20. Smith JS, Roth MJ. Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J Virol 1993, 67:4037-4049. 237771, 7685407.
21. Smith JS, Gritsman K, Roth MJ. Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. J Virol 1994, 68:5721-5729. 236975, 7520094.
22. Tanese N, Goff SP. Domain structure of the Moloney murine leukemia virus reverse transcriptase: Mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc Natl Acad Sci USA 1988, 85:1777-1781. 10.1073/pnas.85.6.1777, 279862, 2450347.
23. Schultz SJ, Champoux JJ. RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. J Virol 1996, 70:8630-8638. 190956, 8970988.
24. Zhan X, Crouch RJ. The isolated RNase H domain of murine leukemia virus reverse transcriptase. retention of activity with concomitant loss of specificity. J Biol Chem 1997, 272:22023-22029. 10.1074/jbc.272.35.22023, 9268341.
25. Lim D, Gregorio GG, Bingman C, Martinez-Hackert E, Hendrickson WA, Goff SP. Crystal structure of the Moloney murine leukemia virus RNase H domain. J Virol 2006, 80:8379-8389. 10.1128/JVI.00750-06, 1563865, 16912289.
26. Iwai S, Wakasa M, Ohtsuka E, Kanaya S, Kidera A, Nakamura H. Interaction of the basic protrusion of Escherichia coli ribonuclease HI with its substrate. J Mol Biol 1996, 263:699-706. 10.1006/jmbi.1996.0609, 8947569.
27. Katayanagi K, Miyagawa M, Matsushima M, Ishikawa M, Kanaya S, Nakamura H, Ikehara M, Matsuzaki T, Morikawa K. Structural details of ribonuclease H from Escherichia coli as refined to an atomic resolution. J Mol Biol 1992, 223:1029-1052. 10.1016/0022-2836(92)90260-Q, 1311386.
28. Yang W, Hendrickson WA, Crouch RJ, Satow Y. Structure of ribonuclease H phased at 2 Å resolution by MAD analysis of the selenomethionyl protein. Science 1990, 249:1398-1405. 10.1126/science.2169648, 2169648.
29. Nowotny M, Gaidamakov SA, Ghirlando R, Cerritelli SM, Crouch RJ, Yang W. Structure of human RNase H1 complexed with an RNA/DNA hybrid: Insight into HIV reverse transcription. Mol Cell 2007, 28:264-276. 10.1016/j.molcel.2007.08.015, 17964265.
30. Kanaya S, Katsuda-Nakai C, Ikehara M. Importance of the positive charge cluster in Escherichia coli ribonuclease HI for the effective binding of the substrate. J Biol Chem 1991, 266:11621-11627.
31. Telesnitsky A, Blain SW, Goff SP. Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H. J Virol 1992, 66:615-622. 240759, 1370551.
32. Lim D, Orlova M, Goff SP. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition. J Virol 2002, 76:8360-8373. 10.1128/JVI.76.16.8360-8373.2002, 155118, 12134040.
33. Davies JF, Hostomska Z, Hostomsky Z, Jordan SR, Matthews DA. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 1991, 252:88-95. 10.1126/science.1707186, 1707186.
34. Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH. Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J Virol 2003, 77:8548-8554. 10.1128/JVI.77.15.8548-8554.2003, 165255, 12857924.
35. Nowotny M, Gaidamakov SA, Crouch RJ, Yang W. Crystal structures of RNase H bound to an RNA/DNA hybrid: Substrate specificity and metal-dependent catalysis. Cell 2005, 121:1005-1016. 10.1016/j.cell.2005.04.024, 15989951.
36. Das D, Georgiadis MM. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure 2004, 12:819-829. 10.1016/j.str.2004.02.032, 15130474.
37. Pfrepper KI, Rackwitz HR, Schnölzer M, Heid H, Löchelt M, Flügel RM. Molecular characterization of proteolytic processing of the pol proteins of human foamy virus reveals novel features of the viral protease. J Virol 1998, 72:7648-7652. 110030, 9696869.
38. Boyer PL, Gao HQ, Frank P, Clark PK, Hughes SH. The basic loop of the RNase H domain of MLV RT is important both for RNase H and for polymerase activity. Virology 2001, 282:206-213. 10.1006/viro.2000.0827, 11259203.
39. Yang W, Lee JY, Nowotny M. Making and breaking nucleic acids: Two-Mg2+-ion catalysis and substrate specificity. Mol Cell 2006, 22:5-13. 10.1016/j.molcel.2006.03.013, 16600865.
40. Steitz TA, Steitz JA. A general two-metal-ion mechanism for catalytic RNA. Proc Natl Acad Sci USA 1993, 90:6498-6502. 10.1073/pnas.90.14.6498, 46959, 8341661.
41. Huber HE, McCoy JM, Seehra JS, Richardson CC. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J Biol Chem 1989, 264:4669-4678.
42. DeStefano JJ, Bambara RA, Fay PJ. Parameters that influence the binding of human immunodeficiency virus reverse transcriptase to nucleic acid structures. Biochemistry (N Y) 1993, 32:6908-6915.
43. Hartl MJ, Kretzschmar B, Frohn A, Nowrouzi A, Rethwilm A, Wöhrl BM. AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. Nucleic Acids Res 2008, 36:1009-1016. 2241919, 18096624.
44. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning - A laboratory manual. 1994, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
45. Hartl MJ, Wöhrl BM, Rösch P, Schweimer K. The solution structure of the simian foamy virus protease reveals a monomeric protein. J Mol Biol 2008, 381:141-149. 10.1016/j.jmb.2008.05.064, 18597783.
46. Bax A, Grzesiek A. Methodological advances in protein NMR. Acc Chem Res 1993, 26:131-138.
47. Sattler M, Schleucher J, Griesinger C. Herteronuclear multidimensional NMR experiments for the structure determination of proteins in solution empolying pulsed field gradients. Prog NMR Spectrosc 1999, 34:93-158.